Evidence map›Paper›PMID 31227566›Full record

ArticleBMJ case reports2019

Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline

Anson Snow, Charite Ricker, Gino K In

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anson SnowDepartment of Medicine, Los Angeles County University of Southern California Medical Center, Los Angeles, California, USA.
Charite RickerDepartment of Medicine, Division of Medical Oncology, University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Gino K InDepartment of Dermatology, University of Southern California - Keck School of Medicine, Los Angeles, California, USA.
Los Angeles Medical Center · USUniversity of Southern California · USUSC Norris Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modernised genetic testing among patients with cancer has led to an increasing wealth of knowledge regarding cancer biology and aetiology. Furthermore, some germline mutations have the potential to direct therapeutic approaches as well. While

Indexed as

BRCA2 ProteinCarcinoma, Renal CellChemoradiotherapy, AdjuvantFemaleGerm-Line MutationHumansMelanomaMiddle AgedMutationNeoplasms, Multiple PrimaryNeoplasm StagingProtein Kinase InhibitorsSorafenibTreatment OutcomeBRCA2 ProteinBRCA2 protein, humanProtein Kinase InhibitorsSorafenibgeneticsoncologyskin cancerurological cancer

Identifiers

PMID31227566
PMCPMC6605957
OpenAlexW2949965113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.